Vor Biopharma Inc. (VOR) financial statements and ratios from SEC XBRL: revenue $5.87M (TTM), net margin -11860.6%, revenue growth 37.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $5.87M |
| Net Margin | -11860.6% |
| Revenue Growth (YoY) | 37.4% |
| EPS Growth (YoY) | 4047.1% |
| FCF Growth (YoY) | 43.8% |
| Price / Sales | 89.65 |
| FCF Yield | -20.9% |
| Altman Z-Score | -3.91 (distress) |
| Sector P/E (Healthcare) | 21.6 |
VOR overview · VOR earnings · VOR KPIs · VOR investor relations · VOR ownership · VOR peers · VOR filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.